Fertility preservation in young patients' with cancer

Dudani, Sharmila; Gupta, Apurva
October 2014
Journal of Mid-life Health;Oct-Dec2014, Vol. 5 Issue 4, p165
Academic Journal
Preservation of fertility is an important issue in the management of young cancer patients. Though embryo cryostorage is a well-established procedure, it can only be availed by couples. Recent studies have indicated increasing success rates with mature and immature oocyte cryopreservation. Cryostorage induces injuries on the human oocytes which can be minimized by slow freezing and vitrification. Selection of candiidates is crucial so that the most suitable technique can be offered without any delay in initiation of cancer therapy. Factors affecting suitability are age of patient, assessment of ovarian reserve, hormonal status and type and stage of neoplastic disease. Encouraging results have been obtained with oocyte in vitro maturation (IVM) followed by vitrification for cryostorage. Data on the use of vitrified eggs in routine in vitro fertilization (IVF) show that pregnancy rates can be comparable to those achieved with fresh oocytes.


Related Articles

  • Case Report of Live Birth in 46 Year Old Woman.  // Fertility Weekly;11/3/2014, p2 

    The article discusses a case study by Susan M. Maxwell and colleagues of a 46-year-old woman who gave birth to a live infant using cyropreserved autologous oocytes. It says that the woman had presented to the authors' fertility center to discuss fertility preservation and chose to proceed with...

  • Storage time does not modify the gene expression profile of cryopreserved human metaphase II oocytes. Stigliani, Sara; Moretti, Stefano; Anserini, Paola; Casciano, Ida; Venturini, Pier Luigi; Scaruffi, Paola // Human Reproduction;Nov2015, Vol. 30 Issue 11, p2519 

    Study Question: Does storage time have any impact on the transcriptome of slowly frozen cryopreserved human metaphase II (MII) oocytes?Summary Answer: The length of cryostorage has no effect on the gene expression profile of human MII oocytes.What Is Known...

  • Embryo Cryopreservation in Female Cancer Patients Yields Satisfactory Live Birth Rate. Thong, K. J. // Fertility Weekly;2/24/2014, p9 

    The article discusses a study on the outcome of embryo cryopreservation in female oncology patients yields satisfactory live birth rate. It states that fertility preservation is an important aspect of cancer treatments in reproductive-aged women due to gonadotoxicity of chemotherapy and...

  • Social egg freezing: A viable option for fertility preservation. Dunne, Caitlin; Roberts, Jeffrey // British Columbia Medical Journal;Dec2016, Vol. 58 Issue 10, p573 

    Social egg freezing is now a viable option for women in our society who wish to preserve their fertility and delay childbearing. Over the past few years, substantial advancements have been made in the egg freezing technique. Evidence from randomized controlled trials has demonstrated that frozen...

  • The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment. Takae, Seido; Sugishita, Yodo; Yoshioka, Nobuhito; Hoshina, Mariko; Horage, Yuki; Sato, Yorino; Nishijima, Chie; Kawamura, Kazuhiro; Suzuki, Nao // Journal of Assisted Reproduction & Genetics;Feb2015, Vol. 32 Issue 2, p305 

    Purpose: To determine the factors that affect oocyte extraction efficiency when using the 'combined procedure'. In the present 'combined procedure' ovarian tissue cryopreservation and oocyte extraction from an isolated ovary, later used in In Vitro Maturation (IVM), are performed concurrently....

  • Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women. So-Youn Kim; Seul Ki Kim; Jung Ryeol Lee; Woodruff, Teresa K. // Journal of Gynecologic Oncology;Mar2016, Vol. 27 Issue 2, p1 

    As the number of young cancer survivors increases, quality of life after cancer treatment is becoming an ever more important consideration. According to a report from the American Cancer Society, approximately 810,170 women were diagnosed with cancer in 2015 in the United States. Among female...

  • Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer. Abdel-Razeq, Hikmat // Cancer Management & Research;May2019, Vol. 11, p4273 

    Breast cancer remains the most common cancer among women worldwide. Many patients, especially in our region, are affected while young and during their child-bearing years. Chemotherapy, more commonly used in this age group, may result in premature ovarian failure and thus negatively impact their...

  • Fertility preservation outcomes may differ by cancer diagnosis. Pavone, Mary Ellen; Hirshfeld-Cytron, Jennifer; Lawson, Angela K.; Smith, Kristin; Kazer, Ralph; Klock, Susan // Journal of Human Reproductive Sciences;Apr-Jun2014, Vol. 7 Issue 2, p111 

    CONTEXT: Cancer survival has improved significantly and maintaining fertility is both a major concern and an important factor for the quality of life in cancer patients. AIMS: To explore differences in oocyte stimulation for fertility preservation (FP) patients based on cancer diagnosis....

  • Information About Research Worldwide.  // Fertility Weekly;8/11/2014, p13 

    The article presents abstracts on fertility research including the impact of levothyroxine treatment on in vitro fertilization, oocyte cryopreservation and clinical pregnancy rate (CPR) and the influence of blastocyst development and outcomes in pre-implantation genetic diagnosis cycles.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics